medigraphic.com
ISSN 1561-3011 (Electronic)

2021, Number 4

<< Back Next >>

Rev Cubana Invest Bioméd 2021; 40 (4)

Methicillin-resistant Staphylococcus spp. and vancomycin-resistant Enterococcus spp. isolated from patients attending the medicine and emergency service at a hospital in northern Peru

Aguilar-Gamboa FR, Tene VFD, Guadalupe VJM, Moreno MMC, Failoc RVE

Language: Spanish
References: 24
Page: 1-13
PDF size: 238.63 Kb.


ABSTRACT

Objective: Determine the frequency of methicillin-resistant Staphylococcus spp. and vancomycin-resistant Enterococcus spp. in asymptomatic patients attending the Medicine and Emergency Service at Lambayeque Regional Hospital in Peru.
Methods: A total 101 patients attending the Medicine and Emergency Service at Lambayeque Regional Hospital were studied from April to August 2017. The nasal, pharyngeal and rectal regions were considered for sample taking. Primary isolation was performed on mannitol salt agar and bile aesculin agar plates supplemented with 6 μg/ml oxacillin and 6 μg/ml vancomycin, respectively. Identification was carried out by classic biochemistry. Antimicrobial susceptibility tests were based on the Kirby-Bauer and minimum inhibitory concentration methods.
Results: A carrier frequency of 83.17% was determined. 94.07% of the Staphylococcus isolates were mecA+ methicillin-resistant in 75%, and 43.33% displayed high-level resistance (>128 μg/ml) to this antimicrobial. Glycopeptide-resistant isolates were not found. Enterococcus exhibited a resistance frequency of 54.29% to vancomycin and 42.84% to teicoplanin. Van A was the prevailing phenotype (37.14%). High-level resistance was also determined in this genus (>128 μg/ml) in 27.50% of the isolates.
Conclusion: A high frequency was observed of carriers of the genera Staphylococcus and Enterococcus. Antimicrobial-multiresistant strains are present in asymptomatic carriers.


REFERENCES

  1. Benoit JB, Frank DN, Bessesen MT. Genomic evolution of Staphylococcus aureus isolates colonizing the nares and progressing to bacteremia. Plos ONE. 2018; 13(5): e0195860. https://doi.org/10.1371/journal.pone.0195860

  2. Phodha T, Riewpaiboon A, Malathum K, Coyte PC. Annual relative increased in inpatient mortality from antimicrobial resistant nosocomial infections in Thailand. Epidemiol Infect. 2019;147:e133. https://doi.org/10.1017/S0950268818003436

  3. Holmes NE, Tong SY, Davis JS, van Hal SJ. Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond. Semin Respir Crit Care Med. 2015;36(1):17-30. doi:10.1055/s-0034-1397040

  4. Corredor NC, López C, Aguilera PA, Prieto LM, Rodríguez-Leguizamón G, Leal AL, et al. An epidemiological and molecular study regarding the spread of vancomycin-resistant Enterococcus faecium in a teaching hospital in Bogotá, Colombia 2016. BMC Infect Dis. 2019; 19, 258. https://doi.org/10.1186/s12879-019-3877-7

  5. Montes O, Milanés R, Álvarez A, Cloronado S, Reyes N. Características moleculares y susceptibilidad a antibióticos de cepas de staphylococcus aureus colonizantes de pacientes con patologías nasales procedentes de Cartagena (Colombia), 2015. Arch Med (Manizales) 2015; 15(2):226-40.

  6. Espinosa CJ, Cortés JA, Castillo JS, Leal AL. Revisión sistemática de la resistencia antimicrobiana en cocos Gram positivos intrahospitalarios en Colombia. Biomédica. 2011;31(1):27. https://doi.org/10.7705/biomedica.v31i1.333

  7. Loyola P, Tordecilla J, Benadof D, Yohannessen K, Acuña M. Factores de riesgo de colonización por Enterococcus spp resistente a vancomicina en pacientes pediátricos hospitalizados con patología oncológica. Rev Chil infectología. 2015;32(4):393-8. http://dx.doi.org/10.4067/S0716-10182015000500004

  8. Patel J, Weinstein M, Eliopoulos G, Jenkins S, Lewis J, Limbago B. M100 Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. Clinical and Laboratory Standards Institute, United State. 2017.

  9. Morosini MI, Cercenado E, Ardanuy C, Torres C. [Phenotypic detection of resistance mechanisms in gram-positive bacteria]. Enferm Infecc Microbiol Clin. 2012;30(6):325-32. doi:10.1016/j.eimc.2011.09.009

  10. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48(suppl 1):5-16.

  11. Sacsaquispe Contreras RE, Velásquez Pomar J. Manual de procedimientos para la prueba de sensibilidad antimicrobiana por el método de disco difusión. Ministerio de Salud del Perú. 2002. p 35-36. Disponible en: ftp://ftp2.minsa.gob.pe/descargas/OGCI/proyectosterminados/Proyecto_vigia/Doc13.pdf

  12. Manassero NC, Navarro M, Rocchi M, di Bella H, Gasparotto AM, Ocaña Carrizo AV, et al. Análisis de 117 episodios de bacteriemia por enterococo: estudio de la epidemiología, microbiología y sensibilidad a los antimicrobianos. Rev Argent Microbiol. 2016;48(4):298-302. https://doi.org/10.1016/j.ram.2016.05.002

  13. Estrada-Roman A, Mendo-Lopez R, Astocondor L, Zervos M, Garcia C. Colonización por enterococo resistente a vancomicina en pacientes internados de un hospital de Lima, Perú. Rev Peru Med Exp Salud Publica. 2017;34(4):666-71.doi: 10.17843/rpmesp.2017.344.2617

  14. Kurtgoz SO, Ozer B, Inci M, Duran N, Yula E. Vancomycin and high-level aminoglycoside resistance in Enterococcus species. Microbiology Research. 2016; 7:6441. https://doi.org/10.4081/mr.2016.6441

  15. Medell M, Hart M, Batista ML. Sensibilidad antimicrobiana in vitro en aislamientos de Enterococcus faecalis y Enterococcus faecium obtenidos de pacientes hospitalizados. Biomédica. 2014;34:50-57. http://dx.doi.org/10.7705/biomedica.v34i0.2122

  16. Lozano C, Torres C. Actualización en la resistencia antibiótica en Gram positivos. Enferm Infecc Microbiol Clin. 2017;35 Suppl 1:2-8. https://doi.org/10.1016/S0213-005X(17)30028-9

  17. Bernal C, Takahashi V, Bogado MEV. Prevalencia de Enterococos resistentes a la vancomicina en un Servicio de Cuidados Intensivos de Adultos. Rev Nac (Itauguá). 2015; 7(1): 24-27. http://dx.doi.org/10.18004/rdn2015.0007.01.024-027.

  18. Bermejo V, Spadaccini L, Elbert GR, Duarte AIE, Erbin M, Cahn P. Prevalencia de Staphylococcus aureus resistente a meticilina en infecciones de piel y partes blandas en pacientes ambulatorios. Medicina(Buenos Aires). 2012;72(4):283-6.

  19. Martinez-Medina RM, Montalvo-Sandoval FD, Magaña-Aquino M, Terán-Figueroa YT, Pérez-Urizar JT. Prevalencia y caracterización genotípica de cepas de Staphylococcus aureus resistente a meticilina aisladas en un hospital regional mexicano. Rev Chil Infectol. 2020; 37(1): 37-44. http://dx.doi.org/10.4067/S0716-10182020000100037

  20. Castellano GM, Perozo MA, Soto DR. Resistencia a oxacilina, eritromicina y gentamicina en cepas de Staphylococcus coagulasa negativa aisladas de hemocultivos. 2016. Kasmera. 44(2):97-110.

  21. Dalhoff A, Schubert S, Vente A. Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum--LactamaseProducing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections. Antimicrob Agents Chemother. 2017; 6:e02446-16. https://doi.org/10.1128/AAC.02446-16

  22. Fernández F S, Cárdenas C M, Elster M C. Incidencia de resistencia constitutiva e inducible a clindamicina en Staphylococcus spp. aislados en un centro ambulatorio. Rev del Inst Nac Hig Rafael Rangel. 2004; 35(2):10-3.

  23. Reyes K, Bardossy AC, Zervos M. Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control. Infect Dis Clin North Am. 2016;30(4):953-965. doi: 10.1016/j.idc.2016.07.009.

  24. Honda H, Krauss MJ, Coopersmith CM, Kollef MH, Richmond AM, Fraser VJ, et al. Staphylococcus aureus Nasal Colonization and Subsequent Infection in Intensive Care Unit Patients: Does Methicillin Resistance Matter?. Infect Control Hosp Epidemiol. 2010 Jun;31(06):584-91. doi: 10.1086/652530.




2020     |     www.medigraphic.com